Suono Bio

Suono Bio

Revolutionizing targeted gastrointestinal treatments

Founded 2017

Foxborough, United States 4 employees Series A Biotechnology, Health Care

Suono Bio is a biotechnology startup founded in 2017, headquartered in the United States. The company is on a mission to revolutionize targeted gastrointestinal treatments through its proprietary drug delivery platform. Unlike traditional methods, Suono Bio's approach enables localized delivery of various therapies without the need for encapsulation. This breakthrough in drug delivery has the potential to significantly enhance the effectiveness of treatments for challenging diseases. The company recently secured a Series A investment on 29 March 2021, with participation from prominent investors including Axil Capital, Gutbrain Ventures, Mizuho Securities Principal Investment, PBJ Capital, and Taiwania Capital Management Corporation. This funding is expected to propel Suono Bio's innovative advancements and further establish its position in the biotechnology and healthcare industries. Suono Bio's commitment to pioneering localized therapeutic delivery has the potential to reshape the landscape of medical treatments, offering promising prospects for both the company and its investors.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	Undisclosed	5	Axil Capital, Gutbrain Ventures +3	29 Mar 2021
Corporate Round	Undisclosed	1	NGK SPARK PLUG CO	21 Apr 2020
Corporate Round	Undisclosed	1	Fujifilm	05 Sep 2018
Seed Round	Undisclosed	2	Polaris Partners, The Engine	19 Sep 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

Undisclosed

Axil Capital, Gutbrain Ventures +3

29 Mar 2021

Corporate Round

Undisclosed

NGK SPARK PLUG CO

21 Apr 2020

Corporate Round

Undisclosed

Fujifilm

05 Sep 2018

Seed Round

Undisclosed

Polaris Partners, The Engine

19 Sep 2017

FAQ About Suono Bio

Revolutionizing targeted gastrointestinal treatments

Suono Bio was founded in 2017.

Suono Bio is headquartered in Foxborough, United States.

Suono Bio operates in Biotechnology and Health Care. Its work centres on drug delivery, localized delivery, small molecules and biologics.

Suono Bio has approximately 4 employees.

Suono Bio has completed 4 funding rounds. The latest funding stage is Series A.

Top alternatives and competitors to Suono Bio include Gennao Bio, Intezyne Technologies, Eterna Therapeutics, Evox Therapeutics Ltd, Combinent Biomedical Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Suono Bio and Gennao Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Suono Bio

Funding Rounds & Investors (4)

Suono Bio Alternatives & Competitors

FAQ About Suono Bio